CMV Antenatal Infection  >>  Cytovene (ganciclovir)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cytovene (ganciclovir) / Roche
NCT00001100: A Phase III Study to Evaluate the Safety and Efficacy of Ganciclovir (Dihydroxypropoxymethyl Guanine [DHPG]) Treatment of Symptomatic Central Nervous System (CNS) Congenital Cytomegalovirus (CMV) Infections.

Completed
3
130
US
ganciclovir
National Institute of Allergy and Infectious Diseases (NIAID)
Cytomegalovirus Infections
 
11/05

Download Options